FDA DDMAC Personnel Changes
Executive Summary
Ken Feather has returned to the Division of Drug Marketing, Advertising and Communications after a nine-month detail to the Center for Devices and Radiological Health. Feather will initially succeed Edward Zimney, MD, as chief of the marketing surveillance and enforcement branch that has purview over drugs approved by the Office of Drug Evaluation II. Zimney joined Immunex on March 7 as head of the Seattle company's Drug Safety department. Feather will eventually move into an advisory position with division-wide responsibilities, such as internal consistency in monitoring and surveillance, quality assurance issues, policy making and training